ITRM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Iterum Therapeutics PLC

NASDAQ | ITRM

0.62

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$29.40M

Market Cap

-

P/E Ratio

-0.81

EPS

$3.02

52 Week High

$0.61

52 Week Low

HEALTHCARE

Sector

ITRM Chart

Recent Chart
Price Action

ITRM Technicals

Tags:

ITRM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$254K
Total Revenue $0
Cost Of Revenue $254K
Costof Goods And Services Sold $254K
Operating Income -$19M
Selling General And Administrative $8M
Research And Development $10M
Operating Expenses $18M
Investment Income Net -
Net Interest Income -$2.5M
Interest Income -
Interest Expense $2.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $284K
Income Before Tax -$25M
Income Tax Expense $240K
Interest And Debt Expense -
Net Income From Continuing Operations -$25M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$19M
Net Income -$25M

Revenue & Profitability

Earnings Performance

ITRM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $45M
Total Current Assets $25M
Cash And Cash Equivalents At Carrying Value $24M
Cash And Short Term Investments $24M
Inventory -
Current Net Receivables $66K
Total Non Current Assets $20M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $20M
Intangible Assets Excluding Goodwill $20M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $596K
Other Non Current Assets -
Total Liabilities $49M
Total Current Liabilities $18M
Current Accounts Payable $251K
Deferred Revenue -
Current Debt -
Short Term Debt $14M
Total Non Current Liabilities $31M
Capital Lease Obligations -
Long Term Debt $31M
Current Long Term Debt $14M
Long Term Debt Noncurrent -
Short Long Term Debt Total $46M
Other Current Liabilities $2.9M
Other Non Current Liabilities -
Total Shareholder Equity -$4.1M
Treasury Stock -
Retained Earnings -$486M
Common Stock $315K
Common Stock Shares Outstanding $20M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$27M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $284K
Capital Expenditures $2K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $18M
Cashflow From Financing $27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$25M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$254K
Total Revenue $0
Cost Of Revenue $254K
Costof Goods And Services Sold $254K
Operating Income -$19M
Selling General And Administrative $8M
Research And Development $10M
Operating Expenses $18M
Investment Income Net -
Net Interest Income -$2.5M
Interest Income -
Interest Expense $2.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $284K
Income Before Tax -$25M
Income Tax Expense $240K
Interest And Debt Expense -
Net Income From Continuing Operations -$25M
Comprehensive Income Net Of Tax -
Ebit -$19M
Ebitda -$19M
Net Income -$25M

ITRM News

ITRM Profile

Iterum Therapeutics PLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company dedicated to the development of innovative anti-infective therapies specifically targeting multidrug-resistant infections. Based in Dublin, Ireland, Iterum focuses on addressing significant unmet medical needs in the U.S. and European markets. By prioritizing solutions that combat antibiotic resistance, the company is establishing itself as a pivotal participant in the antimicrobial treatment sector, with a mission to enhance patient outcomes through advanced, targeted therapeutic options.

NVVE
+17.61%
$0.24
MTC
+390.13%
$1.49
ASST
+15.20%
$1.44
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
RIVN
+24.05%
$15.50
GPUS
+12.96%
$0.39
LNAI
+37.88%
$1.14
PLUG
-8.36%
$2.52
NVDA
+1.26%
$201.21
CHR
+8.10%
$0.13
RUBI
-54.40%
$0.27
T
-0.36%
$24.44
SLDP
+53.69%
$8.63
F
-1.69%
$12.79
AXDX
-61.36%
$0.03
BYND
-1.87%
$1.30
PLTR
-2.34%
$186.26
ADAP
-15.14%
$0.05
WTO
-5.83%
$0.04
AAPL
+0.36%
$270.04
DNN
-2.91%
$2.66
BMNR
-7.93%
$39.46
PINS
-21.31%
$25.89
TSLA
+2.39%
$454.90
CIFR
+7.46%
$24.19
AMD
+2.62%
$256.61
YDKG
-3.51%
$0.05
NFE
+15.54%
$1.55
RXRX
-0.40%
$4.98
SMCI
-9.43%
$42.93
TEVA
+22.06%
$24.97
RMBL
+60.50%
$3.21
DVLT
-9.55%
$1.61
SOFI
+1.70%
$29.87
ADD
-25.47%
$0.05
BITF
+3.77%
$3.98
AAL
+5.91%
$13.39
INTC
+2.46%
$37.94
ETHD
-13.88%
$4.52
SRM
+53.27%
$10.30
BAC
-1.44%
$52.76
SNAP
+0.06%
$7.47
ONDS
-0.75%
$5.91
EPWK
-7.88%
$0.06
ZDAI
+18.33%
$0.54
QS
+12.56%
$17.37
NAKA
-11.88%
$0.78
KDLY
-11.88%
$0.78
KVUE
+2.09%
$16.30
GOOGL
-2.17%
$277.54
VALE
+3.05%
$12.30
FUBO
+7.33%
$3.95
APLD
-5.50%
$31.06
WLGS
-5.57%
$0.04
ACHR
-1.04%
$9.46
TLRY
+3.63%
$1.28
IREN
+9.70%
$73.09
NVO
-0.87%
$47.82
MARA
+3.29%
$17.16
BTG
+1.62%
$4.06
ETWO
0.00%
$3.30
RGTI
+4.81%
$36.87
APPS
+22.90%
$7.27
BBD
-1.15%
$3.41
RIG
+0.76%
$3.93
BURU
-3.24%
$0.28
ABEV
+1.70%
$2.39
RDHL
+15.74%
$1.25
NIO
+3.00%
$7.37
WULF
-0.40%
$14.94
U
+11.87%
$40.13
CAN
+8.55%
$1.20
BTBT
+2.06%
$3.24
HTZ
-4.60%
$6.42
WBD
+1.77%
$23.00
NOK
+0.80%
$6.86
AFMD
-34.94%
$0.18
BW
+35.56%
$5.07
NCLH
-0.43%
$18.70
RIOT
-3.78%
$18.54
QBTS
+4.05%
$30.94
HIMS
+5.35%
$45.08
AG
-7.43%
$10.70
AMZN
+0.05%
$249.46
NVTS
-7.60%
$9.66
PCG
+1.39%
$16.38
CMBM
-7.05%
$3.01
MSPR
-24.83%
$0.49
GRAB
-0.60%
$5.75
CMG
+1.15%
$32.10
KLG
-9.05%
$13.35
JOBY
+3.05%
$15.21
CLOV
-16.19%
$2.95
ALIT
-9.28%
$2.44
XAIR
-5.43%
$1.75
GRYP
-10.38%
$1.38
KHC
-0.65%
$24.17
ORIS
-20.21%
$0.12
PLTD
+1.50%
$6.44
NVVE
+17.61%
$0.24
MTC
+390.13%
$1.49
ASST
+15.20%
$1.44
PFE
-1.45%
$24.30
VHAI
0.00%
$0.00
RIVN
+24.05%
$15.50
GPUS
+12.96%
$0.39
LNAI
+37.88%
$1.14
PLUG
-8.36%
$2.52
NVDA
+1.26%
$201.21
CHR
+8.10%
$0.13
RUBI
-54.40%
$0.27
T
-0.36%
$24.44
SLDP
+53.69%
$8.63
F
-1.69%
$12.79
AXDX
-61.36%
$0.03
BYND
-1.87%
$1.30
PLTR
-2.34%
$186.26
ADAP
-15.14%
$0.05
WTO
-5.83%
$0.04
AAPL
+0.36%
$270.04
DNN
-2.91%
$2.66
BMNR
-7.93%
$39.46
PINS
-21.31%
$25.89
TSLA
+2.39%
$454.90
CIFR
+7.46%
$24.19
AMD
+2.62%
$256.61
YDKG
-3.51%
$0.05
NFE
+15.54%
$1.55
RXRX
-0.40%
$4.98
SMCI
-9.43%
$42.93
TEVA
+22.06%
$24.97
RMBL
+60.50%
$3.21
DVLT
-9.55%
$1.61
SOFI
+1.70%
$29.87
ADD
-25.47%
$0.05
BITF
+3.77%
$3.98
AAL
+5.91%
$13.39
INTC
+2.46%
$37.94
ETHD
-13.88%
$4.52
SRM
+53.27%
$10.30
BAC
-1.44%
$52.76
SNAP
+0.06%
$7.47
ONDS
-0.75%
$5.91
EPWK
-7.88%
$0.06
ZDAI
+18.33%
$0.54
QS
+12.56%
$17.37
NAKA
-11.88%
$0.78
KDLY
-11.88%
$0.78
KVUE
+2.09%
$16.30
GOOGL
-2.17%
$277.54
VALE
+3.05%
$12.30
FUBO
+7.33%
$3.95
APLD
-5.50%
$31.06
WLGS
-5.57%
$0.04
ACHR
-1.04%
$9.46
TLRY
+3.63%
$1.28
IREN
+9.70%
$73.09
NVO
-0.87%
$47.82
MARA
+3.29%
$17.16
BTG
+1.62%
$4.06
ETWO
0.00%
$3.30
RGTI
+4.81%
$36.87
APPS
+22.90%
$7.27
BBD
-1.15%
$3.41
RIG
+0.76%
$3.93
BURU
-3.24%
$0.28
ABEV
+1.70%
$2.39
RDHL
+15.74%
$1.25
NIO
+3.00%
$7.37
WULF
-0.40%
$14.94
U
+11.87%
$40.13
CAN
+8.55%
$1.20
BTBT
+2.06%
$3.24
HTZ
-4.60%
$6.42
WBD
+1.77%
$23.00
NOK
+0.80%
$6.86
AFMD
-34.94%
$0.18
BW
+35.56%
$5.07
NCLH
-0.43%
$18.70
RIOT
-3.78%
$18.54
QBTS
+4.05%
$30.94
HIMS
+5.35%
$45.08
AG
-7.43%
$10.70
AMZN
+0.05%
$249.46
NVTS
-7.60%
$9.66
PCG
+1.39%
$16.38
CMBM
-7.05%
$3.01
MSPR
-24.83%
$0.49
GRAB
-0.60%
$5.75
CMG
+1.15%
$32.10
KLG
-9.05%
$13.35
JOBY
+3.05%
$15.21
CLOV
-16.19%
$2.95
ALIT
-9.28%
$2.44
XAIR
-5.43%
$1.75
GRYP
-10.38%
$1.38
KHC
-0.65%
$24.17
ORIS
-20.21%
$0.12
PLTD
+1.50%
$6.44
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.